Structure-Based Drug Designing Studies Towards Exploring the Potential Anticancer Activity of Selected Phytocompounds Against Histone Deacetylase 10 Protein

Asian Journal of Pharmaceutical and Clinical Research - India
doi 10.22159/ajpcr.2018.v11i12.27944
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Innovare Academic Sciences Pvt Ltd

Related search

Towards Structure-Based Protein Drug Design

Biochemical Society Transactions
Biochemistry
2011English

Histone Deacetylase 10 (HDAC10)

Science-Business eXchange
2013English

Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors

Journal of Biomedicine and Biotechnology
2011English

Histone Deacetylase Enzymes as Potential Drug Targets in Cancer and Parasitic Diseases

Journal of Biomedicine and Biotechnology
2006English

Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies

Molecular Cancer Therapeutics
Cancer ResearchOncology
2006English

Front Cover: Structure–Activity and Structure–Toxicity Relationships of Peptoid‐Based Histone Deacetylase Inhibitors With Dual‐Stage Antiplasmodial Activity (ChemMedChem 9/2019)

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2019English

Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance

Cancer Research
Cancer ResearchOncology
2016English

Genomewide Studies of Histone Deacetylase Function in Yeast

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2000English

Histone Deacetylase 6 (HDAC6); Histone Deacetylase 8 (HDAC8)

Science-Business eXchange
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy